OpenAI, Anthropic and Google have been on the prowl for specialized data to train their AI models, discussing deals with ...

Analysts might anticipate a good upside ahead for CSL shares, but I think this ASX biotech stock is a much better buy.

An unusual tussle over the availability of funds for Apple Tree’s startups led the firm to seek protection from creditors ...

The Khalifa Centre for Genetic Engineering & Biotechnology (KCGEB) continues to drive the UAE’s leadership in genomics and biotechnology by transforming scientific knowledge into practical solutions ...

Vial's INHBE siRNA is a first-in-class, liver-targeted (GalNAc-conjugated) siRNA therapy that silences INHBE and its gene product, Activin E -- Leading key opinion leaders (KOL ...

Gastrointestinal cancers that once resisted checkpoint inhibitors are finally responding to novel combination strategies[1], with the FDA fast-tracking multiple targeted therapies designed to ...

The Industrial Doctoral Landscape and two Doctoral Focal Award programmes – BioProcess, BioAID, and CODE-M – will ...

Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era ...

Two recent studies show the novel therapy works in people with multiple myeloma, but researchers are trying to minimize side ...

Researchers demonstrated that it is feasible to encode executable payloads into synthetic DNA that, once sequenced and ...

Mesoblast Limited (NASDAQ:MESO) is a biotechnology company developing treatments for inflammatory diseases, heart failure, ...